SynAct Pharma’s SEK 136 Million Acquisition of TXP Pharma

Setterwalls has assisted SynAct Pharma AB in the transaction.SynAct Pharma AB announced the acquisition of the Swiss-incorporated biotech company TXP Pharma AG. The acquisition encompasses all…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now